Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone

Cell and Tissue Research

Volumn 324, Issue 3, 2006, Pages 385-394

  Gnainsky, Yulia ^a   Spira, Gadi ^b   Paizi, Melia ^b   Bruck, Raffael ^c   Nagler, Arnon ^d   Genina, Olga ^a   Taub, Rebbeca ^e   Halevy, Orna ^f   Pines, Mark ^a  

^a VOLCANI CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e HOFFMANN LA ROCHE INC   (United States)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Collagen; Egr 1; Fibrosis; Human; p53; PRL 2; Rat

Indexed keywords

COLLAGEN TYPE 1; CYCLIN B1; CYCLIN D1; EARLY GROWTH RESPONSE FACTOR 1; HALOFUGINONE; PROTEIN TYROSINE PHOSPHATASE; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; HEPATOCYTES; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; PIPERIDINES; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE-PHOSPHATASE; QUINAZOLINONES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33646374653     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-005-0092-1     Document Type: Article

References (58)

1. Brenner DA (1998) Signal transduction during liver regeneration. J Gastroenterol Hepatol 13 (Suppl):S93-S95
2. Bruck R, Genina O, Aeed H, Alexiev R, Nagler A, Pines M (2001) Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 3:379-386
3. Carter DA (1998) Expression of a novel rat protein tyrosine phosphatase gene. Biochim Biophys Acta 1442:405-408
4. Cates CA, Michael RL, Stayrook KR, Harvey KA, Burke YD, Randall SK, Crowell PL, Crowell DN (1996) Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 110:49-55
5. DeAngelis RA, Kovalovich K, Cressman DE, Taub R (2001) Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 33:915-924
6. Diamond RH, Cressman DE, Laz TM, Abrams CS, Taub R (1994) PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 14:3752-3762
7. Diamond RH, Peters C, Jung SP, Greenbaum LE, Haber BA, Silberg DG, Traber PG, Taub R (1996) Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am J Physiol 271:G121-G129
8. Fang MA, Glackin CA, Sadhu A, McDougall S (2001) Transcriptional regulation of alpha 2(1) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells. J Cell Biochem 80:550-559
9. Fausto N (2000) Liver regeneration. J Hepatol 32:19-31
10. Fausto N (2001) Liver regeneration: from laboratory to clinic. Liver Transpl 7:835-844
11. Fisher GJ, Datta S, Wang Z, Li XY, Quan T, Chung JH, Kang S, Voorhees JJ (2000) c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 106:663-670
12. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG (1992) The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68:545-560
13. Gnainsky Y, Spira G, Paizi M, Bruck R, Nagler A, Abu-Amara SN, Geiger B, Genina O, Monsonego-Ornan E, Pines M (2004) Halofuginone - an inhibitor of collagen synthesis by rat stellate cells - stimulates insulin-like growth factor binding protein 1 synthesis by hepatocytes. J Hepatol 40:269-277
14. Haber B, Naji L, Cressman D, Taub R (1995) Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: attainment and maintenance of the differentiated state during rapid proliferation. Hepatology 22:906-914
15. Halevy O, Nagler A, Levi-Schaffer F, Genina O, Pines M (1996) Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone. Biochem Pharmacol 52:1057-1063
16. Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX (2002) Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 8:203-207
17. Leu JI, Crissey MS, Craig LE, Taub R (2003a) Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBPβ and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 23:1251-1259
18. Leu JI, Crissey MS, Taub R (2003b) Massive hepatic apoptosis associated with TGF-β1 activation after Fas ligand treatment of IGF binding protein1-deficient mice. J Clin Invest 111:129-139
19. Levi-Schaffer F, Nagler A, Slavin S, Knopov V, Pines M (1996) Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. J Invest Dermatol 106:84-88
20. Levkovitz Y, Baraban JM (2002) A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J Neurosci 22:3845-3854
21. Li W, Liang X, Leu JI, Kovalovich K, Cilibreto G, Taub R (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33:1377-1386
22. Libal-Weksler Y, Gotlibovitz O, Stark AH, Madar Z (2001) Diet and diabetic state modify glycogen synthase activity and expression in rat hepatocytes. J Nutr Biochem 12:458-464
23. McGaha TL, Kodera T, Spiera H, Stan AC, Pines M, Bona CA (2002a) Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. Arthritis Rheum 46:2748-2761
24. McGaha TL, Phelps RG, Spiera H, Bona C (2002b) Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growthfactor-beta-mediated Smad3 activation in fibroblasts. J Invest Dermatol 118:461-470
25. Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276:60-66
26. Mohn KL, Melby AE, Tewari DS, Laz TM, Taub R (1991) The gene encoding rat insulin-like growth factor-binding protein 1 is rapidly and highly induced in regenerating liver. Mol Cell Biol 11:1393-1401
27. Montagna M, Serova O, Sylla BS, Mattel MG, Lenoir GM (1996) Localization of the human phosphotyrosine phosphatase-related genes (h-PRL-1) to chromosome bands 1p35-p34, 17q12-q21, 11q24-q25 and 12q24. Hum Genet 98:738-740
28. Mueller L, Broering DC, Meyer J, Vashist Y, Goettsche J, Wilms C, Rogiers X (2002) The induction of the immediate-early-genes Egr-1, PAI-1 and PRL-1 during liver regeneration in surgical model is related to increased portal flow. J Hepatol 37:606-612
29. Murray AW (2004) Recycling the cell cycle: cyclins revisited. Cell 116:221-234
30. Nagler A, Pines M (1999) Topical treatment of cutaneous chronic graft versus host disease (cGvHD) with halofuginone: a novel inhibitor of collagen type I synthesis. Transplantation 68:1806-1809
31. Nagler A, Firman N, Feferman R, Cotev S, Pines M, Shoshan S (1996) Reduction in pulmonary fibrosis in vivo by halofuginone. Am J Resp Critical Care Med 154:1082-1086
32. Nagler A, Rivkind AI, Raphael J, Levi-Schaffer F, Genina O, Lavelin I, Pines M (1998) Halofuginone - an inhibitor of collagen type I synthesis - prevents post-operation abdominal adhesions formation. Ann Surg 227:575-582
33. Nagler A, Genina O, Lavelin I, Ohana M, Pines M (1999) Halofuginone - an inhibitor of collagen type I synthesis - prevents formation of post-operative adhesions in the rat uterine horn model. Am J Obstet Gyn 180:558-563
34. Nagler A, Gofrit O, Ohana M, Pode D, Genina O, Pines M (2000) The effect of halofuginone, an inhibitor of collagen type I synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model. J Urol 164:1776-1780
35. Nagler A, Ohana M, Shibolet O, Shapira MY, Alper R, Vlodavsky I, Pines M, Ilan Y (2004) Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. Eur J Cancer 40:1397-1403
36. Peng Y, Genin A, Spinner NB, Diamond RH, Taub R (1998) The gene encoding human nuclear protein tyrosine phosphatase, PRL-1. Cloning, chromosomal localization, and identification of an intron enhancer. J Biol Chem 273:17286-17295
37. Peng Y, Du K, Ramirez S, Diamond RH, Taub R (1999) Mitogenic up-regulation of the PRL-1 protein-tyrosine phosphatase gene by Egr-1. J Biol Chem 274:4513-4520
38. Peters CS, Liang X, Li S, Kannan S, Peng Y, Taub R, Diamond RH (2001) ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J Biol Chem 276:13718-13726
39. Pines M, Knopov V, Genina O, Lavelin I, Nagler A (1997a) Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. J Hepatol 26:391-398
40. Pines M, Vlodavsky I, Nagler A (1997b) Halofuginone - a novel anti-fibrotic therapy. Gen Pharmacol 30:445-450
41. Pines M, Vlodavsky I, Nagler A (2000) Halofuginone: from veterinary use to human therapy. Drug Develop Res 50:371-378
42. Pines M, Domb A, Ohana M, Inbar J, Genina O, Aleviev R, Nagler A (2001) Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone. Biochem Pharmacol 62:1221-1227
43. Pines M, Snyder D, Yarkoni S, Nagler A (2003) Halofuginone to treat fibrosis in chronic graft versus host disease and scleroderma. Biol Blood Marrow Transplant 9:417-425
44. Reeves HL, Friedman SL (2002) Activation of hepatic stellate cells - a key issue in liver fibrosis. Front Biosci 7:d808-d826
45. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW (2001) Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49:565-576
46. Si X, Zeng Q, Ng CH, Hong W, Pallen CJ (2001) Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-subunit of geranylgeranyltransferase II. J Biol Chem 276:32875-32882
47. Spira G, Mawasi N, Paizi M, Anbinder N, Genina O, Alexiev R, Pines M (2002) Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. J Hepatol 37:331-339
48. Taub R (1996) Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 10:413-427
49. Taub R, Greenbaum LE, Peng Y (1999) Transcriptional regulatory signals define cytokine-dependent and independent pathways in liver regeneration. Semin Liver Dis 19:117-127
50. Thiel G, Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287-292
51. Uno S, Nakamura M, Seki T, Ariga T (1997) Induction of tissue-type plasminogen activator (tPA) and type-1 plasminogen activator inhibitor (PAI-1) as early growth responses in rat hepatocytes in primary culture. Biochem Biophys Res Commun 239:123-128
52. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36:131-149
53. Wang J, Kirby CE, Herbst R (2002) The tyrosine phosphatase PRL-1 localizes to the endoplasmatic reticulum and the mitotic spindle and is required for normal mitosis. J Biol Chem 277:46659-46668
54. Werner SR, Lee PA, DeCamp MW, Crowell DN, Randall SK, Crowell PL (2003) Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases. Cancer Lett 202:201-211
55. Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, Sowers A, Mitchell JB, Roberts AB, Russo A (2004) Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem 279:15167-15176
56. Zeng Q, Hong W, Tan YH (1998) Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun 244:421-427
57. Zeng Q, Si X, Horstmann H, Xu Y, Hong W, Pallen CJ (2000) Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J Biol Chem 275:21444-21452
58. Zhang W, Chen S (2001) EGR-1, a UV-inducible gene in p53(-/-) mouse cells. Exp Cell Res 266:21-30